(I-BusinessNews.Com, October 07, 2020 ) The lycopene market is estimated to be valued at USD 126 million in 2020 and is projected to reach USD 161 million by 2025, at a CAGR of 5.0% during the forecast period. The increasing number of benefits offered by lycopene in preventive healthcare and its rising applications in an array of industries across the globe is projected to exponentially grow the lycopene market in the coming years.
Lycopene is a carotenoid that gives some fruits and vegetables their red color. Lycopene is majorly present in tomato species known as Solanum lycopersicum, mostly found in Central and South American regions. It is a carotenoid and a phytonutrient substance, and is an essential antioxidant for the human body, which helps in protecting from degenerative diseases. Further, lycopene studies are associated with the prevention of diseases and conditions, including hypothesis, a number of cancers (prostate cancer, digestive tract cancer, bladder cancer, skin cancer, breast cancer, gastric cancer, and cervical cancer), cardiovascular diseases, osteoporosis & other bone disorder, male infertility, hypertension, and other human diseases; it is used in the treatment of various diseases such as human papilloma virus (HPV) infection, asthma, gingivitis, and cataracts, which has resulted in the significant expansion of the lycopene market over the last few years.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104131737
Rising consumption of lycopene in an array of industries due to its functions as a health ingredient and coloring agent
Lycopene is witnessing a rise in consumption in an array of industries including dietary supplements, food, personal care & cosmetics, and pharmaceuticals. It is experiencing this growth due to its properties that mainly includes being a health ingredient, followed by being a coloring agent. The majority of the market share in the global lycopene market was accounted for by the health ingredient property. The coloring agent property has a comparatively smaller share in the global market for lycopene. This is a result of the limited application of lycopene as a coloring agent in the food industry. Also, applications of lycopene as a health ingredient are expanding, which is further expected to boost the growth of lycopene in the global market.
Dietary supplements to record the highest CAGR during the forecast period
The demand for dietary supplements is on the rise in developed and developing countries among the millennial population. Lycopene constitutes to be a key ingredient in the dietary supplements consumed by an individual daily. Also, industry experts foresee the adoption rate for dietary supplements to increase the most in the next five years. Hence, lycopeneÂs key role in the dietary supplement application because of its distinct health benefits is expected to bolster the growth during the forecast period between 2020 and 2025.
The increasing demand for lycopene in the European region due to its growing number of the aging population supported its region-wise dominance in 2019.
Europe comprises the highest number of the aging population. Italy and Germany collectively comprise 32.1% of the total population aging 65 and above. According to experts in the lycopene industry, lycopene aids in the treatment of cataracts occurring in the older population across the globe. Furthermore, lycopene also exhibits anti-aging properties, aiding in the prevention of wrinkles. Hence, the growing aging population in the region is driving the demand for lycopene due to its distinct functionalities, bolstering EuropeÂs market share, globally, throughout the forecast period.
Key players operating in this market include Allied Biotech Corporation (China), Lycored (Israel), DSM (Netherlands), Wellgreen Technology Co Ltd (China), Divis Labs (India), San-Ei Gen F.F.I., Inc (Japan), Dangshang Sannuo Limited (China), DDW (US), Dohler (Germany), Farbest Brands (US), Zhejiang NHU CO. Ltd (China), EID Parry (India), Shaanxi Kingsci Biotechnology Co. Ltd (China), Vidya Herbs (India), XiÂan Pincredit Biotech Co Ltd (China), Hunan Sunshine Bio-Tech Co.Ltd (China), XiÂan Natural Field Bio-Technology Co.,Ltd (China), Plantnat (China), SV AgroFoods (India), and Plamed Green Science Group (China).
MarketsandMarketsÂ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companiesÂ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketsÂ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarketsÂ are tracking global high growth markets following the “Growth Engagement Model Â GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketsÂ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketsÂ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarketsÂs flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra